Clinical Trials List
2023-10-15 - 2033-12-31
Phase III
Not yet recruiting2
Recruiting2
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Tung-Liang Lin 無
- 陳建誠 無
- 王元欽 無
- 陳寧君 無
- Hung Chang 無
- Ming-Chung Kao 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Ya-Ping Chen 無
- Ya-Ting Hsu 無
- 傅蓓安 無
- 顏志傑 無
- Sin-Syue Li 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- - - 無
- Chien-Chin Lin 無
- 袁章祖 無
- Chieh-Lung Cheng 無
- 林明恩 無
- YAO CHI-YUAN 無
- CHENG-HONG TSAI 無
- 田豐銘 無
- HSIN-AN HOU 無
- Tai-Chung Huang 無
- Wen-Chien Chou 無
- MING YAO 無
- Huai-Hsuan Huang 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
28 participants
-
Global
1200 participants
